- Home
- CCEC vs ATRC Comparison
CCEC vs ATRC Comparison
Compare CCEC & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEC
- ATRC
- Stock Information
- Founded
- CCEC 2007
- ATRC 2000
- Country
- CCEC Greece
- ATRC United States
- Employees
- CCEC N/A
- ATRC N/A
- Industry
- CCEC Marine Transportation
- ATRC Medical/Dental Instruments
- Sector
- CCEC Consumer Discretionary
- ATRC Health Care
- Exchange
- CCEC Nasdaq
- ATRC Nasdaq
- Market Cap
- CCEC 1.4B
- ATRC 1.6B
- IPO Year
- CCEC 2007
- ATRC 2005
- Fundamental
- Price
- CCEC $21.59
- ATRC $37.66
- Analyst Decision
- CCEC Buy
- ATRC Strong Buy
- Analyst Count
- CCEC 2
- ATRC 10
- Target Price
- CCEC $24.00
- ATRC $49.60
- AVG Volume (30 Days)
- CCEC 27.0K
- ATRC 705.3K
- Earning Date
- CCEC 07-31-2025
- ATRC 07-29-2025
- Dividend Yield
- CCEC 5.68%
- ATRC N/A
- EPS Growth
- CCEC 62.73
- ATRC N/A
- EPS
- CCEC 4.04
- ATRC N/A
- Revenue
- CCEC $424,701,000.00
- ATRC $499,946,000.00
- Revenue This Year
- CCEC $19.03
- ATRC $14.63
- Revenue Next Year
- CCEC $13.94
- ATRC $12.62
- P/E Ratio
- CCEC $12.52
- ATRC N/A
- Revenue Growth
- CCEC 84.28
- ATRC 16.28
- 52 Week Low
- CCEC $14.09
- ATRC $23.97
- 52 Week High
- CCEC $24.83
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- CCEC 44.98
- ATRC 64.88
- Support Level
- CCEC $20.76
- ATRC $34.91
- Resistance Level
- CCEC $22.36
- ATRC $36.20
- Average True Range (ATR)
- CCEC 1.04
- ATRC 1.15
- MACD
- CCEC -0.09
- ATRC 0.03
- Stochastic Oscillator
- CCEC 27.13
- ATRC 95.16
About CCEC Capital Clean Energy Carriers Corp. Common Share
Capital Clean Energy Carriers Corp is an international shipping company. It is the platform of gas carriage solutions with a focus on the energy transition. The company owns 20 high-specification vessels, including 12 latest-generation LNG carriers (LNG/Cs) and eight legacy Neo-Panamax container vessels.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.